These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38903694)

  • 1. Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S.
    Lichtenberg FR
    J Pharm Policy Pract; 2024; 17(1):2357604. PubMed ID: 38903694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries.
    Lichtenberg FR
    Econ Hum Biol; 2022 Aug; 46():101124. PubMed ID: 35344806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries.
    Mills M; Michaeli D; Miracolo A; Kanavos P
    BMC Health Serv Res; 2023 Feb; 23(1):150. PubMed ID: 36782175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition.
    Michaeli DT; Michaeli T
    Pharmacoeconomics; 2024 Jan; 42(1):117-131. PubMed ID: 37855850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act.
    Grabowski H; Long G
    J Med Econ; 2024; 27(1):463-472. PubMed ID: 38419523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files.
    Lichtenberg FR
    Forum Health Econ Policy; 2013 Jan; 16(1):1-33. PubMed ID: 31419866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.
    Wei Y; Zhang Y; Xu Z; Wang G; Zhou Y; Li H; Shi L; Naci H; Wagner AK; Guan X
    Lancet Reg Health West Pac; 2024 Apr; 45():101055. PubMed ID: 38590780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.
    Zhang Y; Hueser HC; Hernandez I
    J Manag Care Spec Pharm; 2017 Feb; 23(2):247-254. PubMed ID: 28125371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Spending on Drugs With Accelerated Approval.
    Ballreich J; Socal M; Bennett CL; Schoen MW; Trujillo A; Xuan A; Anderson G
    Ann Intern Med; 2022 Jul; 175(7):938-944. PubMed ID: 35605235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Orphan Drug Indications: 2010-2018.
    Kimmel L; Conti RM; Volerman A; Chua KP
    Pediatrics; 2020 Apr; 145(4):. PubMed ID: 32127360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].
    Dumortier G; Welniarz B; Sauvebois C; Medjdoub H; Friche H; Siad N; Degrassat K
    Encephale; 2005; 31(4 Pt 1):477-89. PubMed ID: 16389715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?
    Lichtenberg FR
    Int J Health Econ Manag; 2024 Mar; 24(1):1-31. PubMed ID: 37940731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.
    Zhang Y; Naci H; Wagner AK; Xu Z; Yang Y; Zhu J; Ji J; Shi L; Guan X
    JAMA Netw Open; 2022 Aug; 5(8):e2225973. PubMed ID: 35947385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.
    LaHood A; Rahman R; McKenna L; Frick M; Mitnick CD
    PLoS One; 2022; 17(7):e0271102. PubMed ID: 35877601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.